These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21734565)

  • 41. HIV and interferon regulatory factor 1: a story of manipulation and control.
    Sivro A; Su RC; Plummer FA; Ball TB
    AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1428-33. PubMed ID: 23984938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection?
    Firoz Mian M; Ashkar AA
    Am J Reprod Immunol; 2011 Mar; 65(3):344-51. PubMed ID: 21223417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional polymorphisms in Toll-like receptor genes for innate immunity in farm animals.
    Novák K
    Vet Immunol Immunopathol; 2014 Jan; 157(1-2):1-11. PubMed ID: 24268689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. APOBEC family proteins: novel antiviral innate immunity.
    Takaori-Kondo A
    Int J Hematol; 2006 Apr; 83(3):213-6. PubMed ID: 16720550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistance to HIV infection.
    Marmor M; Hertzmark K; Thomas SM; Halkitis PN; Vogler M
    J Urban Health; 2006 Jan; 83(1):5-17. PubMed ID: 16736351
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of HLA-B α-3 domain amino acid position 194 in HIV disease progression.
    Grifoni A; Montesano C; Palma P; Salerno A; Colizzi V; Amicosante M
    Mol Immunol; 2013 Apr; 53(4):410-3. PubMed ID: 23103378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Innate immunity against HIV-1 infection.
    Altfeld M; Gale M
    Nat Immunol; 2015 Jun; 16(6):554-62. PubMed ID: 25988887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Cellular restriction factors that inhibit human immunodeficiency virus replication: new strategies in antiretroviral therapy].
    Moreno-Valencia Y; Alvarez-García LX; Vázquez-Pérez JA
    Rev Invest Clin; 2014; 66(4):359-68. PubMed ID: 25695302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TRIM5 gene polymorphisms in HIV-1-infected patients and healthy controls from Northeastern Brazil.
    Celerino da Silva R; Coelho AV; Arraes LC; Brandão LA; Crovella S; Guimarães RL
    Immunol Res; 2016 Dec; 64(5-6):1237-1242. PubMed ID: 27388872
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression.
    Peng G; Greenwell-Wild T; Nares S; Jin W; Lei KJ; Rangel ZG; Munson PJ; Wahl SM
    Blood; 2007 Jul; 110(1):393-400. PubMed ID: 17371941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gut-homing Δ42PD1
    Cheung AKL; Kwok HY; Huang Y; Chen M; Mo Y; Wu X; Lam KS; Kong HK; Lau TCK; Zhou J; Li J; Cheng L; Kiat Lee B; Peng Q; Lu X; An M; Wang H; Shang H; Zhou B; Wu H; Xu A; Yuen KY; Chen Z
    Nat Microbiol; 2017 Oct; 2(10):1389-1402. PubMed ID: 28808299
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SAMHD1 host restriction factor: a link with innate immune sensing of retrovirus infection.
    Sze A; Olagnier D; Lin R; van Grevenynghe J; Hiscott J
    J Mol Biol; 2013 Dec; 425(24):4981-94. PubMed ID: 24161438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy.
    Reis EC; da Silva LT; da Silva WC; Rios A; Duarte AJ; Oshiro TM; Crovella S; Pontillo A
    Hum Vaccin Immunother; 2018; 14(8):1995-2002. PubMed ID: 29641325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands.
    Jennes W; Verheyden S; Demanet C; Adjé-Touré CA; Vuylsteke B; Nkengasong JN; Kestens L
    J Immunol; 2006 Nov; 177(10):6588-92. PubMed ID: 17082569
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Friend or Foe: Innate Sensing of HIV in the Female Reproductive Tract.
    Roan NR; Jakobsen MR
    Curr HIV/AIDS Rep; 2016 Feb; 13(1):53-63. PubMed ID: 26879654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TRIM5α H43Y Polymorphism and Susceptibility to HIV-1 Infection: A Meta-Analysis.
    Deng J; Chen Y; Ding D; Lu P; Yang X; Song Z; Zhu H
    AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1213-8. PubMed ID: 26398573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aging of the human innate immune system in HIV infection.
    Zapata HJ; Shaw AC
    Curr Opin Immunol; 2014 Aug; 29():127-36. PubMed ID: 24997358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune activation and the role of TLRs and TLR agonists in the pathogenesis of HIV-1 infection in the humanized mouse model.
    Chang JJ; Altfeld M
    J Infect Dis; 2013 Nov; 208 Suppl 2(Suppl 2):S145-9. PubMed ID: 24151321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly.
    Kollmann TR; Levy O; Montgomery RR; Goriely S
    Immunity; 2012 Nov; 37(5):771-83. PubMed ID: 23159225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.